----item----
version: 1
id: {BA052AD7-AC5F-40AC-9249-91FFD621BADE}
database: master
path: /sitecore/content/Pharma/MedtechInsight/Home/Articles/Mergers amp Acquisitions 2011
parent: {D5B965D3-AC3D-4A7F-90E6-65193022C6B5}
name: Mergers amp Acquisitions 2011
master: {00000000-0000-0000-0000-000000000000}
template: {11380B5D-3531-4570-B213-EFC5312266E4}
templatekey: Article

----field----
field: {A4F985D9-98B3-4B52-AAAF-4344F6E747C6}
name: __Workflow
key: __workflow
content-length: 38

{926E6200-EB76-4AD4-8614-691D002573AC}
----version----
language: en
version: 1
revision: b8be8bb9-cd67-44b6-90c2-aa4ae26596e2

----field----
field: {5BA0578F-65B7-4C22-8233-1603D698D8A4}
name: Summary
key: summary
content-length: 1161

<p> <tbody> <tr> </tr> <tr> <td> <tbody> <tr> <td>The latest medtech deals, as and when it happens<a></a><br> <em>By Madeleine Armstrong, Editor, Business</em><br> In order to keep track of the busy medtech mergers and acquisitions market, Clinica brings to you its &lsquo;live&rsquo; M&amp;A table. Featuring the latest transactions in the medical device arena, the table features all pending and closed deals of 2011 so far. </td> </tr> <tr> <td><strong><a>M&amp;A 2012</a></strong></td> <td><strong>M&amp;A 2011</strong></td> <td><strong><a>M&amp;A 2010</a></strong></td> <td><strong><a>FREE TRIAL</a></strong></td> </tr> </tbody> </td> </tr> <tr> <td><a></a></td> <td><div><a></a></div></td> <td><a></a></td> <td><div><a></a></div></td> <td><a></a></td> <td><a></a></td> <td><a></a></td> <td><a></a></td> </tr> <tr> <td><div><a>Deals</a></div></td> <td><div><a>M&amp;A </a></div></td> <td><div><a>Financials</a></div></td> <td><div><a>Funding </a></div></td> <td><div><a>Legal</a></div></td> <td><div><a>Start-ups &amp; SMEs </a></div></td> <td><div><a>Market Monitor </a></div></td> <td><div><a>Google Map: M&amp;A 2010 </a></div></td> </tr> </tbody>  </p>
----field----
field: {2D750EFF-9058-4ABF-A7FF-57FFE5DA1E3C}
name: Title
key: title
content-length: 31

Mergers &amp; Acquisitions 2011
----field----
field: {446A339B-E1D9-4DE1-8B5E-DB7942EF1723}
name: Body
key: body
content-length: 85986

<p><table> <tbody> <tr> </tr> <tr> <td colspan="8" scope="row" widtd="101"><table> <tbody> <tr> <td colspan="4" scope="row" widtd="101">The latest medtech deals, as and when it happens<a name="top" id="top"></a><br> <em>By Madeleine Armstrong, Editor, Business</em><br> In order to keep track of the busy medtech mergers and acquisitions market, Clinica brings to you its &lsquo;live&rsquo; M&amp;A table. Featuring the latest transactions in the medical device arena, the table features all pending and closed deals of 2011 so far. </td> </tr> <tr> <td bgcolor="#666666" scope="row" widtd="101"><strong><a href="http://www.clinica.co.uk/MnA/" class="optionsLink">M&amp;A 2012</a></strong></td> <td bgcolor="#CCCCCC" scope="row" widtd="101"><strong>M&amp;A 2011</strong></td> <td bgcolor="#666666" scope="row" widtd="101"><strong><a href="http://www.clinica.co.uk/MnA/_2010/" class="optionsLink">M&amp;A 2010</a></strong></td> <td bgcolor="#666666" scope="row" widtd="101"><strong><a href="http://www.clinica.co.uk/freetrial/" class="optionsLink">FREE TRIAL</a></strong></td> </tr> </tbody> </table></td> </tr> <tr> <td><a href="http://www.clinica.co.uk/business/"><img src="-/media/A41DB0E6789340E3BBE2BB586EBE4293.ashx" alt="Deals" width="80" height="80" border="0" style="margin-left: 5px; margin-right: 5px; margin-bottom: 5px"></a></td> <td scope="row" widtd="101"><div><a href="http://www.clinica.co.uk/business/manda/"><img src="-/media/1594690D6C314ABFA668C2F281D90DEC.ashx" alt="M&amp;A" width="80" height="80" border="0" style="margin-left: 5px; margin-right: 5px; margin-bottom: 5px"></a></div></td> <td><a href="http://www.clinica.co.uk/business/financials/"><img src="-/media/873669F6772642DC9C0C091A39B44486.ashx" alt="Financials" width="80" height="80" border="0" style="margin-left: 5px; margin-right: 5px; margin-bottom: 5px"></a></td> <td><div><a href="http://www.clinica.co.uk/business/funding/"><img src="-/media/B1AB1227A20C433897DB3C8B2F140E45.ashx" alt="Funding" width="80" height="80" border="0" style="margin-left: 5px; margin-right: 5px; margin-bottom: 5px"></a></div></td> <td><a href="http://www.clinica.co.uk/business/legal/"><img src="-/media/7D0516FC157A4E1F896F543962188904.ashx" alt="Legal" width="80" height="80" border="0" style="margin-left: 5px; margin-right: 5px; margin-bottom: 5px"></a></td> <td><a href="http://www.clinica.co.uk/business/start-upssmes/"><img src="-/media/66EE0878ED2E4CEC9D21449351C40077.ashx" alt="Start-ups &amp; SMEs" width="80" height="80" border="0" style="margin-left: 5px; margin-right: 5px; margin-bottom: 5px"></a></td> <td><a href="http://www.clinica.co.uk/business/marketmonitor/"><img src="-/media/808B4B2204F542438455FA3DB83F4C28.ashx" alt="Market Monitor" width="80" height="80" border="0" style="margin-left: 5px; margin-right: 5px; margin-bottom: 5px"></a></td> <td><a href="http://www.clinica.co.uk/ma2/"><img src="-/media/7183F022AB364B8C8C43E7EC13518288.ashx" alt="Google Map" width="80" height="80" border="0" style="margin-left: 5px; margin-right: 5px; margin-bottom: 5px"></a></td> </tr> <tr> <td scope="row" widtd="101"><div><a href="http://www.clinica.co.uk/business/" class="optionsLink">Deals</a></div></td> <td scope="row" widtd="101"><div><a href="http://www.clinica.co.uk/business/manda/" class="optionsLink">M&amp;A </a></div></td> <td><div><a href="http://www.clinica.co.uk/business/financials/" class="optionsLink">Financials</a></div></td> <td><div><a href="http://www.clinica.co.uk/business/funding/" class="optionsLink">Funding </a></div></td> <td><div><a href="http://www.clinica.co.uk/business/legal/" class="optionsLink">Legal</a></div></td> <td><div><a href="http://www.clinica.co.uk/business/start-upssmes/" class="optionsLink">Start-ups &amp; SMEs </a></div></td> <td><div><a href="http://www.clinica.co.uk/business/marketmonitor/" class="optionsLink">Market Monitor </a></div></td> <td><div><a href="http://www.clinica.co.uk/ma2/" class="optionsLink">Google Map: M&amp;A 2010 </a></div></td> </tr> </tbody> </table> </p> <p><p> <table> <tr> <th bgcolor="#C5E2E2" scope="col"> <p> Acquirer </p> </th> <th bgcolor="#C5E2E2" scope="col"> <p> Target </p> </th> <th bgcolor="#C5E2E2" scope="col"> <p> Industry sector </p> </th> <th bgcolor="#C5E2E2" scope="col"> <p> Price paid </p> </th> <th bgcolor="#C5E2E2" scope="col"> <p> Date announced </p> </th> <th bgcolor="#C5E2E2" scope="col"> <p> Date completed </p> </th> </tr> <tr> <td> <p> <b>DECEMBER 2011</b> </p> </td> <td><p></td> <td><p></td> <td><p></td> <td><p></td> <td><p></td> </tr> <tr> <td> <p> <b>Avacta (UK)</b> </p> </td> <td> <p> AptuScan (UK) </p> </td> <td> <p> Diagnostics, biotech R&amp;D and bioprocessing </p> </td> <td> <p> &pound;1.48m ($2.31m) </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/ivds/Avacta-seeks-to-raise-5m-to-buy-new-reagents-platform-325306">30/12/2011</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>OPKO Health (US)</b> </p> </td> <td> <p> FineTech Pharmaceutical (Israel) </p> </td> <td> <p> Active pharmaceutical ingredients (for diagnostics and therapeutics) </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/ivds/OPKO-Health-to-acquire-API-producer-FineTech-325152?autnID=/contentstore/clinica/codex/487a0700-2ca8-11e1-93c4-6dbe5a318e04.xml">22/12/2011</a> </p> </td> <td> <p> 29/12/2011 </p> </td> </tr> <tr> <td> <p> <b>3DISC Imaging (US)</b> </p> </td> <td> <p> CoreWare (South Korea) </p> </td> <td> <p> Diagnostic imaging software </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/imagingit/3DISC-Imaging-grabs-imaging-software-firm-in-maiden-acquisition-325153?autnID=/contentstore/clinica/codex/5461010c-2c98-11e1-93c4-6dbe5a318e04.xml">22/12/2011</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>CR Bard (US)</b> </p> </td> <td> <p> Lutonix (US) </p> </td> <td> <p> Cardiology (drug-eluting balloons) </p> </td> <td> <p> Up to $325m ($225m upfront and $100m if drug-eluting balloon approved) </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/cardiovascular/Bard-gains-promising-balloon-tech-with-Lutonix-buy-325066">21/12/2011</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Mindray Medical International (China)</b> </p> </td> <td> <p> Greenlander Information Technology (China) </p> </td> <td> <p> Diagnostic imaging IT </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/ivds/Mindray-strengthens-IVD-and-medical-imaging-units-with-stakes-in-TDR-Biotech-and-Greenlander-325067">21/12/2011</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Mindray Medical International (China)</b> </p> </td> <td> <p> Hunan Changsha Tiandiren Biotech (China) </p> </td> <td> <p> In vitro diagnostics </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/ivds/Mindray-strengthens-IVD-and-medical-imaging-units-with-stakes-in-TDR-Biotech-and-Greenlander-325067">21/12/2011</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Vermillion (US)</b> </p> </td> <td> <p> Correlogic Systems (US) </p> </td> <td> <p> In vitro diagnostics </p> </td> <td> <p> $435,000 </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/ivds/Vermillion-scoops-up-bankrupt-Correlogic-to-help-develop-next-gen-ovarian-cancer-test-325014">20/12/2011</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Sanomedics (US)</b> </p> </td> <td> <p> Durable Medical Equipment (US) </p> </td> <td> <p> Sleep apnoea treatment </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 20/12/2011 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Fujifilm (Japan)</b> </p> </td> <td> <p> SonoSite (US) </p> </td> <td> <p> Diagnostic imaging </p> </td> <td> <p> $995m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/imagingit/Fujifilms-near-1bn-SonoSite-buy-highlights-ultrasound-MandA-flurry-324873">15/12/2011</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Electrochem Solutions (US)</b> </p> </td> <td> <p> Micro Power Electronics (US) </p> </td> <td> <p> Batteries for portable medical devices </p> </td> <td> <p> $60m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/business/manda/Greatbatch-subsidiary-acquires-medical-battery-maker-Micro-Power-324767?autnID=/contentstore/clinica/codex/b040f2a4-2649-11e1-93c4-6dbe5a318e04.xml">14/12/2011</a> </p> </td> <td> <p> 15/12/2011 </p> </td> </tr> <tr> <td> <p> <b>Baxter International (US)</b> </p> </td> <td> <p> Synovis Life Technologies (US) </p> </td> <td> <p> Soft tissue repair products for surgery </p> </td> <td> <p> $325m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/cellulargenetic/Baxter-splashes-out-260m-on-biomaterials-firm-Synovis-324707?autnID=/contentstore/clinica/codex/56aacb48-25a9-11e1-93c4-6dbe5a318e04.xml">13/12/2011</a> </p> </td> <td> <p> 14/02/2012 </p> </td> </tr> <tr> <td> <p> <b>Symmetry Medical (US)</b> </p> </td> <td> <p> Codman &amp; Shurtleff surgical instruments business </p> </td> <td> <p> Surgical instruments </p> </td> <td> <p> $165m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/surgicalwoundcare/Symmetry-to-boost-surgical-offering-with-purchase-of-JandJs-Codman-and-Shurtleff-324695?autnID=/contentstore/clinica/codex/4287d6f7-259c-11e1-93c4-6dbe5a318e04.xml">13/12/2011</a> </p> </td> <td> <p> 29/12/2011 </p> </td> </tr> <tr> <td> <p> <b>HealthpointCapital (US)</b> </p> </td> <td> <p> Blue Belt Technologies (US) </p> </td> <td> <p> Surgical instruments </p> </td> <td> <p> Undisclosed </p> </td> <td><p></td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/surgicalwoundcare/Private-equity-firm-buys-smart-surgical-instrument-developer-Blue-Belt-324654?autnID=/contentstore/clinica/codex/6d21bf96-24c9-11e1-93c4-6dbe5a318e04.xml">12/12/2011</a> </p> <p></td> </tr> <tr> <td> <p> <b>Roche (Switzerland)</b> </p> </td> <td> <p> Verum Diagnostica (Germany) </p> </td> <td> <p> In vitro diagnostics (platelet function testing) </p> </td> <td> <p> Up to &euro;13m ($17.4m): &euro;11m upfront and up to &euro;2m in milestones </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/ivds/Roche-gains-platelet-function-test-offering-with-Verum-acquisition-324403?autnID=/contentstore/clinica/codex/3257773d-1fff-11e1-93c4-6dbe5a318e04.xml">7/12/2011</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Wound Management Technologies (US)</b> </p> </td> <td> <p> Juventas (US) </p> </td> <td> <p> Wound care </p> </td> <td> <p> 12.5 million shares (potentially rising to 22.5 million shares) </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/surgicalwoundcare/Wound-Management-Technologies-gains-distributor-network-with-Juventas-buy-324352?autnID=/contentstore/clinica/codex/91fcb439-1f69-11e1-93c4-6dbe5a318e04.xml">6/12/2011</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Affymetrix (US)</b> </p> </td> <td> <p> eBioscience (US) </p> </td> <td> <p> In vitro diagnostics </p> </td> <td> <p> $330m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/ivds/Affymetrix-diversifies-with-330m-eBioscience-buy-324338?autnID=/contentstore/clinica/codex/f24476ab-1f60-11e1-93c4-6dbe5a318e04.xml">5/12/2011</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Advanced Medical Solutions (UK)</b> </p> </td> <td> <p> Resorba (Germany) </p> </td> <td> <p> Wound care </p> </td> <td> <p> &euro;64m ($86m) </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/surgicalwoundcare/AMS-on-verge-of-win-win-acquisition-of-Resorba-for-64m-324305?autnID=/contentstore/clinica/codex/8e58f203-1cfe-11e1-9dc5-03d09a1632b1.xml">2/12/2011</a> </p> </td> <td> <p> 20/12/2011 </p> </td> </tr> <tr> <td> <p> <b>Alere (US)</b> </p> </td> <td> <p> Arriva Medical (US) </p> </td> <td> <p> Diabetes testing supplies </p> </td> <td> <p> $65m plus 806,452 Alere shares </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/ivds/Alere-expands-POC-diabetes-offering-with-Arriva-buy-324263?autnID=/contentstore/clinica/codex/53b9bc94-1c2e-11e1-9dc5-03d09a1632b1.xml">1/12/2011</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>NOVEMBER</b> </p> </td> <td><p></td> <td><p></td> <td><p></td> <td><p></td> <td><p></td> </tr> <tr> <td> <p> <b>Covidien (Ireland)</b> </p> </td> <td> <p> B&Acirc;RRX Medical (US) </p> </td> <td> <p> Radiofrequency ablation </p> </td> <td> <p> $325m plus undisclosed royalties </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/surgicalwoundcare/Covidien-swallows-BRRX-for-325m-323948?autnID=/contentstore/clinica/codex/6e77a649-14fa-11e1-bbe6-4d8e6a53eb99.xml">22/11/2011</a> </p> </td> <td> <p> 5/1/2011 </p> </td> </tr> <tr> <td> <p> <b>Bain Capital (US)</b> </p> </td> <td> <p> Physio-Control (US) </p> </td> <td> <p> Emergency products and services </p> </td> <td> <p> $487m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/Medtronic-finally-offloads-Physio-Control-unit-to-private-equity-firm-for-487m-323837">18/11/2011</a> </p> </td> <td> <p> 30/1/2012 </p> </td> </tr> <tr> <td> <p> <b>Samsung (South Korea)</b> </p> </td> <td> <p> Nexus (US) </p> </td> <td> <p> Point-of-care diagnostics </p> </td> <td> <p> Undisclosed </p> </td> <td><p></td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/ivds/Samsung-buys-into-cardiac-Dx-as-medtech-stake-grows-323733?autnID=/contentstore/clinica/codex/607b05ad-1062-11e1-bbe6-4d8e6a53eb99.xml">16/11/2011</a> </p> </td> </tr> <tr> <td> <p> <b>Zimmer (US)</b> </p> </td> <td> <p> ExtraOrtho (US) </p> </td> <td> <p> Orthopaedics (bone fixation) </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/orthopaedics/Zimmer-strengthens-trauma-offering-with-ExtraOrtho-buy-323708?autnID=/contentstore/clinica/codex/995a02cc-0fac-11e1-bbe6-4d8e6a53eb99.xml">16/11/2011</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Positron (US)</b> </p> </td> <td> <p> Mahattan Isotope Technology (US) </p> </td> <td> <p> PET imaging agents </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 14/11/2011 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Leica Microsystems (Germany)</b> </p> </td> <td> <p> Microscopy and histopathology units of Labindia Instruments (India) </p> </td> <td> <p> Microscopy and histopathology </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> 14/11/2011 </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Evonik Industries (Germany)</b> </p> </td> <td> <p> SurModics (US) </p> </td> <td> <p> Pharmaceuticals (SurModics to focus on device and diagnostics business) </p> </td> <td> <p> $30m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/other/SurModics-offloads-pharma-assets-to-Evonik-medtech-focus-paying-off-323153?autnID=/contentstore/clinica/codex/92ae308a-054f-11e1-bbe6-4d8e6a53eb99.xml">2/11/2011</a> </p> </td> <td> <p> November 2011 </p> </td> </tr> <tr> <td> <p> <b>Everist Genomics (US)</b> </p> </td> <td> <p> Angiologix (US) </p> </td> <td> <p> Cardiovascular disease detection </p> </td> <td> <p> Undisclosed </p> </td> <td><p></td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/cardiovascular/Everist-gains-early-stage-CV-detection-tech-with-Angiologix-purchase-323127?autnID=/contentstore/clinica/codex/7ec584b1-0494-11e1-bbe6-4d8e6a53eb99.xml">1/11/2011</a> </p> </td> </tr> <tr> <td> <p> <b>OCTOBER</b> </p> </td> <td><p></td> <td><p></td> <td><p></td> <td><p></td> <td><p></td> </tr> <tr> <td> <p> <b>Optim (US)</b> </p> </td> <td> <p> Precision Endoscopic Technologies (US) </p> </td> <td> <p> Haemorrhoid treatment (endoscopy accessory) </p> </td> <td><p></td> <td><p></td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/other/Optim-expands-into-therapeutic-endoscopy-with-Precision-buy-323074?autnID=&amp;REFID=DLYALT">31/10/2011</a> </p> </td> </tr> <tr> <td> <p> <b>Cellectis (France)</b> </p> </td> <td> <p> Cellartis (Sweden) </p> </td> <td> <p> Stem cells </p> </td> <td> <p> &euro;16.4m plus 1.93 million shares totalling &euro;12.74m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/cellulargenetic/Cellectis-soon-to-close-Cellartis-buy-with-50m-fundraising-323071?autnID=&amp;REFID=DLYALT">31/10/2011</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Mystaire (US)</b> </p> </td> <td> <p> Misonix (US) </p> </td> <td> <p> Fume hoods and forensic products </p> </td> <td> <p> $1.5m </p> </td> <td><p></td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/imagingit/Misonix-offloads-non-core-business-to-focus-exclusively-on-surgical-devices-323022?autnID=/contentstore/clinica/codex/01694189-0167-11e1-a40e-a1abd6bfdf9a.xml">28/10/2011</a> </p> </td> </tr> <tr> <td> <p> <b>CR Bard (US)</b> </p> </td> <td> <p> Medivance (US) </p> </td> <td> <p> Trauma (temperature control devices) </p> </td> <td> <p> $250m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/other/Bard-splashes-out-250m-on-hypothermia-firm-Medivance-spending-cuts-help-Q3-growth-322913?autnID=/contentstore/clinica/codex/5cfa8da8-ffc1-11e0-a40e-a1abd6bfdf9a.xml">26/10/2011</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>AAR Corp (US)</b> </p> </td> <td> <p> Teleflex (US) </p> </td> <td> <p> Cargo systems and container aerospace (Teleflex selling off to become pure-play medtech firm) </p> </td> <td> <p> $280m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/Teleflex-casts-off-final-non-medical-business-to-hone-focus-on-devices-322775">24/10/2011</a> </p> </td> <td> <p> 2/12/2011 </p> </td> </tr> <tr> <td> <p> <b>W L Gore (US)</b> </p> </td> <td> <p> NMT Medical (US) </p> </td> <td> <p> Cardiovascular </p> </td> <td> <p> Undisclosed </p> </td> <td><p></td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/cardiovascular/Gore-buys-assets-of-bankrupt-hole-in-heart-specialist-NMT-322683?autnID=/contentstore/clinica/codex/0d8428ef-fb08-11e0-a40e-a1abd6bfdf9a.xml">20/10/2011</a> </p> </td> </tr> <tr> <td> <p> <b>Ametek (US)</b> </p> </td> <td> <p> Reichert Technologies (US) </p> </td> <td> <p> Ophthalmology devices </p> </td> <td> <p> $150m </p> </td> <td><p></td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/other/Ametek-eyes-ophthalmic-market-with-150m-Reichert-buy-322642?autnID=/contentstore/clinica/codex/5daa538b-fa3c-11e0-9740-ab88f098ad2d.xml">19/10/2011</a> </p> </td> </tr> <tr> <td> <p> <b>OPKO Health (US)</b> </p> </td> <td> <p> Claros Diagnostics (US) </p> </td> <td> <p> Point-of-care diagnostics </p> </td> <td> <p> Undisclosed </p> </td> <td><p></td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/ivds/OPKO-homes-in-on-POC-diagnostics-with-Claros-buy-322469?autnID=/contentstore/clinica/codex/c668af65-f654-11e0-9740-ab88f098ad2d.xml">14/10/2011</a> </p> </td> </tr> <tr> <td> <p> <b>DASA (Diagn�sticos da América SA, Brazil)</b> </p> </td> <td> <p> MD1 Participa&ccedil;&otilde;es (MD1, Brazil) </p> </td> <td> <p> In vitro diagnostics </p> </td> <td> <p> RS$1.8bn </p> </td> <td><p></td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/ivds/Brazils-DASA-seals-MD1-buy-as-international-expansion-beckons-322498?autnID=/contentstore/clinica/codex/8571307b-f4f4-11e0-9740-ab88f098ad2d.xml">14/10/2011</a> </p> </td> </tr> <tr> <td> <p> <b>Precision Engineered Products (US)</b> </p> </td> <td> <p> Boston Endo-Surgical Technologies (US) </p> </td> <td> <p> Spinal surgery </p> </td> <td> <p> Undisclosed </p> </td> <td><p></td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/orthopaedics/PEP-buys-Boston-Endo-Surgical-Technologies-to-strengthen-spinal-surgery-unit-322098">7/10/2011</a> </p> </td> </tr> <tr> <td> <p> <b>ConvaTec (US)</b> </p> </td> <td> <p> Farnhurst Medical (UK) </p> </td> <td> <p> Stoma and incontinence care </p> </td> <td> <p> Undisclosed </p> </td> <td><p></td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/surgicalwoundcare/ConvaTec-increases-UK-stoma-offering-with-Farnhurst-acquisition-322056">6/10/2011</a> </p> </td> </tr> <tr> <td> <p> <b>Alere (US)</b> </p> </td> <td> <p> Axis-Shield (UK, Norway) </p> </td> <td> <p> IVDs </p> </td> <td> <p> &pound;235m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/ivds/Alere-finally-bags-Axis-Shield-with-slightly-increased-offer-322066?autnID=/contentstore/clinica/codex/d68d4232-f026-11e0-9740-ab88f098ad2d.xml">6/10/2011</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>The Carlyle Group and Hellman &amp; Friedman (US)</b> </p> </td> <td> <p> PPD (US) </p> </td> <td> <p> Contract research organisation for medtech and pharma </p> </td> <td> <p> $3.9bn </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/cellulargenetic/PPD-bought-by-US-investors-for-3.9bn-321971">4/10/2011</a> </p> </td> <td> <p> 5/12/2011 </p> </td> </tr> <tr> <td> <p> <b>Ethicon Endo-Surgery (US)</b> </p> </td> <td> <p> SterilMed (US) </p> </td> <td> <p> Reprocessing and remanufacturing </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/JandJs-Ethicon-gains-reprocessing-tech-with-SterilMed-takeover-321969?autnID=/contentstore/clinica/codex/3fc10255-edd7-11e0-9740-ab88f098ad2d.xml">4/10/2011</a> </p> </td> <td> <p> 4/11/2011 </p> </td> </tr> <tr> <td> <p> <b>Getinge (Sweden)</b> </p> </td> <td> <p> Atrium Medical (US) </p> </td> <td> <p> Cardiovascular </p> </td> <td> <p> $680m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/cardiovascular/Getinge-boosts-cardiovascular-presence-further-with-680m-Atrium-Medical-buy-321936?autnID=/contentstore/clinica/codex/02721f4d-edb2-11e0-9740-ab88f098ad2d.xml">3/10/2011</a> </p> </td> <td> <p> 7/11/2011 </p> </td> </tr> <tr> <td> <p> <b>SEPTEMBER</b> </p> </td> <td><p></td> <td><p></td> <td><p></td> <td><p></td> <td><p></td> </tr> <tr> <td> <p> <b>NuVasive (US)</b> </p> </td> <td> <p> Impulse Monitoring (US) </p> </td> <td> <p> Neuromonitoring </p> </td> <td> <p> $80m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/neurological/NuVasive-buys-leading-US-intra-operative-monitoring-service-provider-to-increase-XLIF-penetration-321910">30/9/2011</a> </p> </td> <td> <p> 7/10/2011 </p> </td> </tr> <tr> <td> <p> <b>Sony (Japan)</b> </p> </td> <td> <p> Micronics (US) </p> </td> <td> <p> In vitro diagnostics </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/ivds/Sony-buys-POC-Dx-company-to-step-up-medtech-RandD-efforts-321834?autnID=/contentstore/clinica/codex/3e604387-ea89-11e0-9740-ab88f098ad2d.xml">29/9/2011</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Aton (Germany)</b> </p> </td> <td> <p> OrthoScan (US) </p> </td> <td> <p> Diagnostic imaging </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/imagingit/Aton-makes-second-mobile-X-ray-imaging-investment-with-OrthoScan-buy-321782?autnID=/contentstore/clinica/codex/4659a0fa-e9e0-11e0-9740-ab88f098ad2d.xml">28/9/2011</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Aesculap (Germany)</b> </p> </td> <td> <p> Aragon Surgical (US) </p> </td> <td> <p> Surgical instruments </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/surgicalwoundcare/Aragon-buy-strengthens-Aesculaps-advanced-energy-portfolio-321786?autnID=/contentstore/clinica/codex/18cda4ed-e9d9-11e0-9740-ab88f098ad2d.xml">28/9/2011</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Tunstall Healthcare Group (UK)</b> </p> </td> <td> <p> American Medical Alert Corp (US) </p> </td> <td> <p> Telehealth/remote patient monitoring </p> </td> <td> <p> $82.3m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/imagingit/Telehealth-firm-Tunstall-expands-remote-monitoring-with-AMAC-buy-321618?autnID=/contentstore/clinica/codex/94452b9b-e830-11e0-adf5-7973089f72e8.xml">26/9/2011</a> </p> </td> <td> <p> 22/12/2011 </p> </td> </tr> <tr> <td> <p> <b>Optos (UK)</b> </p> </td> <td> <p> OPKO Health Instrumentation division (US) </p> </td> <td> <p> Ophthalmology (retinal imaging) </p> </td> <td> <p> $17.5m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/other/Optos-focuses-on-retinal-diagnostics-with-OPKO-Instrumentation-purchase-321516?autnID=/contentstore/clinica/codex/989c300c-e503-11e0-adf5-7973089f72e8.xml">22/9/2011</a> </p> </td> <td> <p> 11/10/2011 </p> </td> </tr> <tr> <td> <p> <b>Varian Medical Systems (US)</b> </p> </td> <td> <p> Calypso Medical Technologies (US) </p> </td> <td> <p> Tumour tracking for radiotherapy </p> </td> <td> <p> $10m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/other/Varian-makes-a-move-for-tumour-tracking-specialist-Calypso-321450">20/09/2011</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>CR Bard (US)</b> </p> </td> <td> <p> ClearStream Technologies (Ireland) </p> </td> <td> <p> Cardiovascular (angioplasty) </p> </td> <td> <p> &pound;43.8m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/cardiovascular/Bard-strengthens-vascular-offering-with-69m-ClearStream-acquisition-321447">20/09/2011 </a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Natus Medical (US)</b> </p> </td> <td> <p> Embla Systems (US) </p> </td> <td> <p> Sleep diagnostics </p> </td> <td> <p> $16.1m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/other/Natus-swings-to-number-one-in-sleep-apnoea-market-with-Embla-buy-321351?autnID=/contentstore/clinica/codex/89c585c2-e2bb-11e0-adf5-7973089f72e8.xml&amp;REFID=DLYALT">19/09/2011</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Integra LifeSciences (US)</b> </p> </td> <td> <p> Ascension Orthopedics (US) </p> </td> <td> <p> Orthopaedics (extremity implants) </p> </td> <td> <p> $65m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/orthopaedics/Integra-adds-upper-extremity-strength-with-Ascension-buy-321093?autnID=/contentstore/clinica/codex/314179c0-ddf7-11e0-adf5-7973089f72e8.xml">13/09/2011</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>PerkinElmer (US)</b> </p> </td> <td> <p> Caliper Life Sciences (US) </p> </td> <td> <p> Molecular imaging and detection technology for research </p> </td> <td> <p> $600m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/imagingit/PerkinElmer-grabs-Caliper-for-600m-to-boost-research-portfolio-321044?autnID=/contentstore/clinica/codex/3edadf5a-dd48-11e0-adf5-7973089f72e8.xml">12/09/2011</a> </p> </td> <td> <p> 7/11/2011 </p> </td> </tr> <tr> <td> <p> <b>ConvaTec (US)</b> </p> </td> <td> <p> Boston Medical Device (Latin America) </p> </td> <td> <p> Wound and ostomy care </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/surgicalwoundcare/ConvaTec-buys-BMD-to-strengthen-supply-chain-outside-US-320686?autnID=/contentstore/clinica/codex/ee56f466-d554-11e0-adf5-7973089f72e8.xml">02/09/2011</a> </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/surgicalwoundcare/ConvaTec-buys-BMD-to-strengthen-supply-chain-outside-US-320686?autnID=/contentstore/clinica/codex/ee56f466-d554-11e0-adf5-7973089f72e8.xml">02/09/2011</a> </p> </td> </tr> <tr> <td> <p> <b>Stryker (US)</b> </p> </td> <td> <p> Concentric Medical (US) </p> </td> <td> <p> Neurovascular (stroke treatment) </p> </td> <td> <p> $135m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/cardiovascular/Stryker-continues-diversification-with-Concentric-buy-but-does-it-have-one-eye-on-SandN-320626?autnID=/contentstore/clinica/codex/3f54c463-d48a-11e0-adf5-7973089f72e8.xml">01/09/2011</a> </p> </td> <td> <p> 10/10/2011 </p> </td> </tr> <tr> <td> <p> <b>AUGUST</b> </p> </td> <td><p></td> <td><p></td> <td><p></td> <td><p></td> <td><p></td> </tr> <tr> <td> <p> <b>Spire Healthcare (UK)</b> </p> </td> <td> <p> Lifescan (UK) </p> </td> <td> <p> Diagnostic imaging </p> </td> <td> <p> &pound;1.37m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/imagingit/Spire-aims-to-increase-patient-numbers-with-Lifescan-acquisition-320556?autnID=/contentstore/clinica/codex/aa730424-d3c4-11e0-adf5-7973089f72e8.xml">31/08/2011</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>CAE Healthcare (Canada)</b> </p> </td> <td> <p> Medical Education Technologies Inc (US) </p> </td> <td> <p> Medical simulation technology </p> </td> <td> <p> $130m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/imagingit/CAE-expands-healthcare-simulation-offering-with-METI-buy-320502?autnID=/contentstore/clinica/codex/5de47634-cff7-11e0-adf5-7973089f72e8.xml">30/08/2011</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Baxter International (US)</b> </p> </td> <td> <p> Baxa (US) </p> </td> <td> <p> Drug delivery </p> </td> <td> <p> $380m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/other/Baxter-makes-380m-grab-for-Baxa-to-boost-IV-and-oral-delivery-320510?autnID=/contentstore/clinica/codex/166c23e3-d2ee-11e0-adf5-7973089f72e8.xml">30/08/2011</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Zynex Medical (US)</b> </p> </td> <td> <p> NeuroDyne Medical (US) </p> </td> <td> <p> Neurodiagnostics </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/neurological/Zynex-to-acquire-NeuroDyne-in-bid-to-strengthen-neurodiagnostic-portfolio-320473?autnID=/contentstore/clinica/codex/e77e411e-cfeb-11e0-adf5-7973089f72e8.xml">26/08/2011</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Vasomedical (US)</b> </p> </td> <td> <p> Life Enhancement Technology (LET) and Biox Instruments (both China) </p> </td> <td> <p> Cardiovascular disease treatment and monitoring </p> </td> <td> <p> $1m upfront for both companies </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/cardiovascular/Vasomedical-buys-China-based-partners-to-strengthen-manufacturing-and-supply-chain---UPDATE-320470?autnID=/contentstore/clinica/codex/5811d214-cfe8-11e0-adf5-7973089f72e8.xml">24/08/2011</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Medrad (US)</b> </p> </td> <td> <p> Pathway Medical Technologies (US) </p> </td> <td> <p> Peripheral arterial disease treatment </p> </td> <td> <p> $125m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/cardiovascular/Bayers-Medrad-to-expand-PAD-offering-with-rumoured-Pathway-purchase-320330">23/08/2011 </a> </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/cardiovascular/Bayers-Medrad-nabs-Pathway---its-official-320635?autnID=/contentstore/clinica/codex/273fa3fd-d4a1-11e0-adf5-7973089f72e8.xml">1/09/2011</a> </p> </td> </tr> <tr> <td> <p> <b>GE Healthcare (UK)</b> </p> </td> <td> <p> PAA Laboratories (Austria) </p> </td> <td> <p> Biomanufacturing </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/business/manda/GE-strengthens-upstream-bioprocessing-capabilities-with-PAA-purchase-320168?autnID=/contentstore/clinica/codex/2b18c658-ca6b-11e0-adf5-7973089f72e8.xml">19/08/2011</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>General Dynamics (US)</b> </p> </td> <td> <p> Vangent (US) </p> </td> <td> <p> Healthcare IT </p> </td> <td> <p> $960m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/imagingit/General-Dynamics-strengthens-healthcare-IT-offering-with-near-1bn-Vangent-acquisition-320052">17/08/2011</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Modern Mobility Aids (US)</b> </p> </td> <td> <p> LumiGene Technologies (Canada) </p> </td> <td> <p> Molecular diagnostics </p> </td> <td> <p> Can$1m upfront plus Can$480,000 milestone payment </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/ivds/Mobility-devices-co-makes-maiden-Dx-buy-with-180-turntowards-pharma-and-biotech-strategy-319788?autnID=/contentstore/clinica/codex/f4df12fc-c407-11e0-ae40-ed65f51b1d22.xml">11/08/2011</a> </p> </td> <td> <p> November 2011 </p> </td> </tr> <tr> <td> <p> <b>Symmetry Medical (US)</b> </p> </td> <td> <p> Olsen Medical (US) </p> </td> <td> <p> Electrosurgical instruments </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/orthopaedics/Symmetry-to-buy-electrosurgical-specialist-Olsen-319584?autnID=/contentstore/clinica/codex/4bf5ad24-beb3-11e0-ae40-ed65f51b1d22.xml">05/08/2011</a> </p> </td> <td> <p> 18/08/2011 </p> </td> </tr> <tr> <td> <p> <b>Thoratec (US)</b> </p> </td> <td> <p> Levitronix Medical (US) </p> </td> <td> <p> Heart support devices </p> </td> <td> <p> $110m upfront plus $40m in milestone payments </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/cardiovascular/Thoratec-cements-No1-heart-support-position-with-Levitronix-Medical-acquisition-319545?autnID=/contentstore/clinica/codex/095da25d-bea4-11e0-ae40-ed65f51b1d22.xml">04/08/2011</a> </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/cardiovascular/Thoratec-cements-No1-heart-support-position-with-Levitronix-Medical-acquisition-319545?autnID=/contentstore/clinica/codex/095da25d-bea4-11e0-ae40-ed65f51b1d22.xml">04/08/2011 </a> </p> </td> </tr> <tr> <td> <p> <b>Cantel Medical (US)</b> </p> </td> <td> <p> Byrne Medical (US) </p> </td> <td> <p> Endoscopy </p> </td> <td> <p> $100m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/other/Byrne-buy-bolsters-Cantels-endoscopy-offering-319473">03/08/2011</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Fresenius Medical Care (Germany)</b> </p> </td> <td> <p> American Access Care (US) </p> </td> <td> <p> Dialysis </p> </td> <td> <p> $385m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/other/Fresenius-increases-dialysis-stranglehold-with-2bn-Liberty-and-AAC-spree-319464">03/08/2011</a> </p> </td> <td> <p> July 2011 </p> </td> </tr> <tr> <td> <p> <b>Fresenius Medical Care (Germany)</b> </p> </td> <td> <p> Liberty Dialysis (US) </p> </td> <td> <p> Dialysis </p> </td> <td> <p> $1.7bn </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/other/Fresenius-increases-dialysis-stranglehold-with-2bn-Liberty-and-AAC-spree-319464">03/08/2011</a> </p> </td> <td> <p> March 2012 </p> </td> </tr> <tr> <td> <p> <b>Becton Dickinson (US)</b> </p> </td> <td> <p> Carmel Pharma (Sweden) </p> </td> <td> <p> Drug transfer tech </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/Quarterly-results-round-up-BD-beats-estimates-Hologic-solid-again-319453?autnID=/contentstore/clinica/codex/09e9aa98-bdba-11e0-ae40-ed65f51b1d22.xml">03/08/2011</a> </p> </td> <td> <p> 16/08/2011 </p> </td> </tr> <tr> <td> <p> <b>JULY</b> </p> </td> <td><p></td> <td><p></td> <td><p></td> <td><p></td> <td><p></td> </tr> <tr> <td> <p> <b>Hologic (US)</b> </p> </td> <td> <p> Beijing Healthcome Technology Company (China) </p> </td> <td> <p> Mammography </p> </td> <td> <p> $16.9m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/Quarterly-results-round-up-BD-beats-estimates-Hologic-solid-again-319453">03/08/2011</a> </p> </td> <td> <p> July 2011 </p> </td> </tr> <tr> <td> <p> <b>OraSure Technologies (US)</b> </p> </td> <td> <p> DNA Genotek (Canada) </p> </td> <td> <p> Molecular diagnostics </p> </td> <td> <p> $53m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/ivds/DNA-Genotek-buy-takes-OraSure-into-fast-growing-molecular-Dx-segment-319052?autnID=/contentstore/clinica/codex/6acca5a5-b778-11e0-90aa-37843338bafc.xml">26/07/2011</a> </p> </td> <td> <p> 18/08/2011 </p> </td> </tr> <tr> <td> <p> <b>bioMérieux (France)</b> </p> </td> <td> <p> Argene (France) </p> </td> <td> <p> In vitro diagnostics </p> </td> <td> <p> Up to &euro;42.5m (&euro;37.5m upfront plus milestones of up to &euro;5m) </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/ivds/bioMerieux-expands-infectious-disease-test-offering-with-Argene-buy-318834?autnID=/contentstore/clinica/codex/ec0a4060-b382-11e0-90aa-37843338bafc.xml">21/07/2011</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Thermo Fisher Scientific (US)</b> </p> </td> <td> <p> Magellan Biosciences' TREK Diagnostics Systems (US) </p> </td> <td> <p> In vitro diagnostics (microbiology testing) </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/ivds/Magellan-offloads-microbiology-business-to-Thermo-Fisher-to-focus-on-clinical-Dx-318668?autnID=/contentstore/clinica/codex/19b47a6f-b20a-11e0-b701-4f12144b74c2.xml">19/07/2011</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Roche Diagnostics (Switzerland)</b> </p> </td> <td> <p> mtm laboratories (Germany) </p> </td> <td> <p> In vitro diagnostics </p> </td> <td> <p> &euro;190m (&euro;130m upfront plus up to &euro;60 in milestone payments) </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/ivds/Roche-broadens-cervical-cancer-offering-with-190m-mtm-buy-318661">19/07/2011</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>NeoStem (US)</b> </p> </td> <td> <p> Amorcyte (US) </p> </td> <td> <p> Stem cells </p> </td> <td> <p> $10m up fron, plus $2m in warrants, and $6m in potential milestones (all in shares) </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/cellulargenetic/NeoStem-expands-into-cardiovascular-space-with-Amorcyte-buy-318532?autnID=/contentstore/clinica/codex/290d2746-aee0-11e0-b701-4f12144b74c2.xml">15/07/2011</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Private equity consortium made up of Apax Partners, the Canada Pension Plan Investment Board, and Public Sector Pension Investment Board</b> </p> </td> <td> <p> Kinetic Concepts (US) </p> </td> <td> <p> Wound care </p> </td> <td> <p> $6.3bn </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/surgicalwoundcare/Private-equity-consortium-bags-Kinetic-Concepts-for-6.3bn-318419?autnID=/contentstore/clinica/codex/0d4b1bf3-ad5b-11e0-b701-4f12144b74c2.xml">13/07/2011</a> </p> </td> <td> <p> 4/11/2011 </p> </td> </tr> <tr> <td> <p> <b>Olympus (Japan)</b> </p> </td> <td> <p> Spirus Medical (US) </p> </td> <td> <p> Endoscopy </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/other/Olympus-buys-Spirus-consolidates-endoscopy-leadership-318354">July 2011</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Medtronic (US)</b> </p> </td> <td> <p> Salient Surgical Technologies (US) </p> </td> <td> <p> Surgical technology </p> </td> <td> <p> $480m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/surgicalwoundcare/Medtronic-spends-585m-to-buy-out-surgical-tech-investments-318227?autnID=/contentstore/clinica/codex/6dd9883d-a952-11e0-b701-4f12144b74c2.xml">July 2011</a> </p> </td> <td> <p> August 2011 </p> </td> </tr> <tr> <td> <p> <b>Medtronic (US) </b> </p> </td> <td> <p> PEAK Surgical (US)<b> </b> </p> </td> <td> <p> Surgical technology<b> </b> </p> </td> <td> <p> $105m<b> </b> </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/surgicalwoundcare/Medtronic-spends-585m-to-buy-out-surgical-tech-investments-318227?autnID=/contentstore/clinica/codex/6dd9883d-a952-11e0-b701-4f12144b74c2.xml">July 2011</a> <b> </b> </p> </td> <td> <p> <b> </b>August 2011 </p> </td> </tr> <tr> <td> <p> <b>Mindray Medical International (China)</b> </p> </td> <td> <p> Suzhou Hyssen Electronics (China) </p> </td> <td> <p> Automated urine sediment analysers </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/other/Chinas-Mindray-fills-gap-in-urinalysis-with-Hyssen-buy-transaction-follows-Shenke-318183?autnID=/contentstore/clinica/codex/7636794b-a8a0-11e0-b701-4f12144b74c2.xml">July 2011</a> </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/other/Chinas-Mindray-fills-gap-in-urinalysis-with-Hyssen-buy-transaction-follows-Shenke-318183?autnID=/contentstore/clinica/codex/7636794b-a8a0-11e0-b701-4f12144b74c2.xml">July 2011</a> </p> </td> </tr> <tr> <td> <p> <b>ResMed (US)</b> </p> </td> <td> <p> BiancaMed (Ireland) </p> </td> <td> <p> Sleep and breathing monitoring </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/BiancaMed-buy-expand-ResMeds-product-and-patient-reach-318177?autnID=/contentstore/clinica/codex/3ee81e79-a8a3-11e0-b701-4f12144b74c2.xml">July 2011</a> </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/BiancaMed-buy-expand-ResMeds-product-and-patient-reach-318177?autnID=/contentstore/clinica/codex/3ee81e79-a8a3-11e0-b701-4f12144b74c2.xml">July 2011</a> </p> </td> </tr> <tr> <td> <p> <b>Transonic (US)</b> </p> </td> <td> <p> Scisense (Canada) </p> </td> <td> <p> Cardiovascular research (merger) </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/cardiovascular/Cardiovascular-research-specialists-Transonic-and-SciSense-merge-318170?autnID=/contentstore/clinica/codex/03d10cac-a88a-11e0-b701-4f12144b74c2.xml">July 2011</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>DASA (Diagn�sticos da América SA, Brazil)</b> </p> </td> <td> <p> Cytolab (Brazil) </p> </td> <td> <p> Clinical analysis and pathology </p> </td> <td> <p> R$11.1m </p> </td> <td><p></td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/ivds/Double-DASA-acquisition-bolsters-path-lab-dominance-in-Brazil-318133?autnID=/contentstore/clinica/codex/9e155532-a7cc-11e0-b701-4f12144b74c2.xml">July 2011</a> </p> </td> </tr> <tr> <td> <p> <b>DASA (Diagn�sticos da América SA, Brazil)</b> </p> </td> <td> <p> Previlab (Brazil) </p> </td> <td> <p> Clinical analysis and pathology </p> </td> <td> <p> R$11.8m </p> </td> <td><p></td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/ivds/Double-DASA-acquisition-bolsters-path-lab-dominance-in-Brazil-318133?autnID=/contentstore/clinica/codex/9e155532-a7cc-11e0-b701-4f12144b74c2.xml">July 2011</a> </p> </td> </tr> <tr> <td> <p> <b>CareFusion (US)</b> </p> </td> <td> <p> Rowa (Germany) </p> </td> <td> <p> Robotic storage systems </p> </td> <td> <p> $150m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/business/manda/CareFusion-purchases-robotic-storage-specialist-Rowa-for-150m-in-bid-for-international-growth-318128?autnID=/contentstore/clinica/codex/b8acb80b-a7de-11e0-b701-4f12144b74c2.xml">July 2011</a> </p> </td> <td> <p> August 2011 </p> </td> </tr> <tr> <td> <p> <b>TPG Capital (US) </b> </p> </td> <td> <p> Immucor (US) </p> </td> <td> <p> Blood screening </p> </td> <td> <p> $1.97bn </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/ivds/PE-firm-to-buy-blood-tech-leader-Immucor-for-nearly-2bn---but-will-there-be-better-deals-ahead-318122?autnID=/contentstore/clinica/codex/9498c108-a7b6-11e0-b701-4f12144b74c2.xml">July 2011</a> </p> </td> <td> <p> 19/08/2011 </p> </td> </tr> <tr> <td> <p> <b>JUNE</b> </p> </td> <td><p></td> <td><p></td> <td><p></td> <td><p></td> <td><p></td> </tr> <tr> <td> <p> <b>Philips (the Netherlands) </b> </p> <p></td> <td> <p> Sectra Mamea (Sweden) </p> <p></td> <td> <p> Digital mammography </p> <p></td> <td> <p> &euro;57.5m + &euro;12.5m earnout </p> <p></td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/imagingit/Sectra-offloads-loss-making-digital-mammography-line-to-Philips-to-focus-on-med-IT-317737?autnID=/contentstore/clinica/codex/9365ffd2-a0cd-11e0-9623-f78bfbd2136f.xml">June 2011</a> </p> <p></td> <td> <p> September 2011 </p> </td> </tr> <tr> <td> <p> <b>Smith &amp; Nephew Endoscopy (US) </b> </p> <p></td> <td> <p> Tenet Medical Engineering (Canada) </p> <p></td> <td> <p> Endoscopy </p> <p></td> <td> <p> Undisclosed </p> <p></td> <td><p></td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/surgicalwoundcare/SandN-Endoscopy-gains-patient-positioning-portfolio-awarded-85m-in-Arthrex-case-317659">June 2011 </a> </p> <p></td> </tr> <tr> <td> <p> <b>Luminex (US) </b> </p> <p></td> <td> <p> EraGen Biosociences (US) </p> <p></td> <td> <p> In vitro diagnostics </p> <p></td> <td> <p> $34m </p> <p></td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/ivds/Luminex-buys-EraGen-Biosciences-gains-new-PCR-platform-317604">June 2011</a> </p> </td> <td> <p> June 2011 </p> </td> </tr> <tr> <td> <p> <b>Dentsply International (US) </b> </p> <p></td> <td> <p> Astra Tech (Sweden) </p> <p></td> <td> <p> Dental/orthodontic; surgery </p> <p></td> <td> <p> $1.8bn </p> <p></td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/surgicalwoundcare/Dentsply-confirms-1.8bn-Astra-Tech-buy-deal-propels-firm-to-No-3-in-dental-implants-317533">June 2011</a> </p> </td> <td> <p> August 2011 </p> </td> </tr> <tr> <td> <p> <b>Elekta (Sweden)</b> </p> </td> <td> <p> Nucletron (the Netherlands) </p> </td> <td> <p> Radiotherapy/radiosurgery </p> </td> <td> <p> &euro;365m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/other/Elekta-grabs-No1-brachytherapy-spot-with-Nucletron-purchase-317453?autnID=/contentstore/clinica/codex/2f823847-9bf9-11e0-bf5b-890e4a5c74f1.xml">June 2011</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Cord Blood America (US)</b> </p> </td> <td> <p> NeoCells (US) </p> </td> <td> <p> Stem cell storage </p> </td> <td> <p> $320,000 </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/cellulargenetic/Cord-Blood-America-gains-new-customers-with-NeoCells-acquisition-317396?autnID=/contentstore/clinica/codex/2174abf9-9b2e-11e0-bf5b-890e4a5c74f1.xml">June 2011</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Qiagen (the Netherlands)</b> </p> </td> <td> <p> Ipsogen (France) </p> </td> <td> <p> In vitro diagnostics </p> </td> <td> <p> $101m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/home/Qiagen-further-invests-in-cancer-Dx-portfolio-with-Ipsogen-buy-317219">June 2011</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>PerkinElmer (US)</b> </p> </td> <td> <p> Dexela (UK) </p> </td> <td> <p> Diagnostic imaging (X-ray technology) </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/imagingit/PerkinElmer-boosts-imaging-offering-with-Dexela-buy-317206?autnID=/contentstore/clinica/codex/600fa7d0-967a-11e0-bf5b-890e4a5c74f1.xml">June 2011</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>LecTec (US)</b> </p> </td> <td> <p> AxoGen (US) </p> </td> <td> <p> Cellular therapies (peripheral nerve repair) </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/surgicalwoundcare/AxoGen-gains-capital-with-LecTec-merger-316893?autnID=/contentstore/clinica/codex/1d524e86-91bb-11e0-bf5b-890e4a5c74f1.xml">June 2011</a> </p> </td> <td> <p> 30/09/2011 </p> </td> </tr> <tr> <td> <p> <b>Merge Healthcare (US)</b> </p> </td> <td> <p> Ophthalmic Imaging Systems (US) </p> </td> <td> <p> Imaging </p> </td> <td> <p> $30m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/imagingit/Merge-to-enter-ophthalmic-imaging-market-by-purchasing-OIS-316797?autnID=/contentstore/clinica/codex/7459fbe8-90fb-11e0-bf5b-890e4a5c74f1.xml">June 2011</a> </p> </td> <td> <p> August 2011 </p> </td> </tr> <tr> <td> <p> <b>Stryker (US)</b> </p> </td> <td> <p> Memometal Technologies (France) </p> </td> <td> <p> Orthopaedics (extremity implants) </p> </td> <td> <p> $162m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/orthopaedics/Stryker-goes-to-extremities-with-162m-Memometal-buy-316830?autnID=/contentstore/clinica/codex/301f758d-90f5-11e0-bf5b-890e4a5c74f1.xml">June 2011</a> </p> </td> <td> <p> July 2011 </p> </td> </tr> <tr> <td> <p> <b>Insulet (US)</b> </p> </td> <td> <p> Neighborhood Diabetes (US) </p> </td> <td> <p> Diabetes products </p> </td> <td> <p> $63m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/business/manda/Insulets-maiden-buy-expands-diabetes-offering-and-grows-customer-base-over-three-fold-316619">June 2011</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>ConvaTec (US)</b> </p> </td> <td> <p> Trent Direct (UK) </p> </td> <td> <p> Delivery services </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/surgicalwoundcare/ConvaTec-expands-UK-home-delivery-operations-316491?autnID=/contentstore/clinica/codex/3b3dd5e3-8d16-11e0-9998-cd6799e9fa2e.xml">June 2011</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Hologic (US)</b> </p> </td> <td> <p> TCT International (China) </p> </td> <td> <p> Distribution </p> </td> <td> <p> $135m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/other/Hologic-gains-direct-foothold-in-China-with-TCT-acquisition-316490?autnID=/contentstore/clinica/codex/7e5ee042-8d03-11e0-9998-cd6799e9fa2e.xml">June 2011</a> </p> </td> <td> <p> June 2011 </p> </td> </tr> <tr> <td> <p> <b>Laboratory Corporation of America (LabCorp, US)</b> </p> </td> <td> <p> Clearstone Central Laboratories (Canada) </p> </td> <td> <p> Lab services </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/business/manda/LabCorp-boosts-global-lab-service-offering-with-Clearstone-purchase-316422?autnID=/contentstore/clinica/codex/7f9beac3-8cf7-11e0-9998-cd6799e9fa2e.xml">June 2011</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>MAY</b> </p> </td> <td><p></td> <td><p></td> <td><p></td> <td><p></td> <td><p></td> </tr> <tr> <td> <p> <b>Histogenics (US)</b> </p> </td> <td> <p> ProChon Biotech (US) </p> </td> <td> <p> Orthopaedic (cartilage regeneration) </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/cellulargenetic/Histogenics-grows-presence-in-cartilage-repair-market-with-ProChon-buy-316313?autnID=/contentstore/clinica/codex/14cfe170-8b74-11e0-924a-2d015a14d1e4.xml">May 2011</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Kensey Nash (US)</b> </p> </td> <td> <p> Norian (US) </p> </td> <td> <p> Orthopaedic (bone cement) </p> </td> <td> <p> $22m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/orthopaedics/Kensey-Nash-cements-position-in-bone-market-with-22m-Norian-buy-316193?autnID=/contentstore/clinica/codex/2068313a-8799-11e0-9076-f763394e0062.xml">May 2011</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Devicor Medical Products (US)</b> </p> </td> <td> <p> Neoprobe (US) </p> </td> <td> <p> Diagnostic imaging </p> </td> <td> <p> $30m upfront plus up to $20m in royalties </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/imagingit/Neoprobe-offloads-gamma-detection-devices-to-focus-on-drug-development-316208?autnID=/contentstore/clinica/codex/2bb615d8-87a2-11e0-9076-f763394e0062.xml">May 2011</a> </p> </td> <td> <p> 17/08/2011 </p> </td> </tr> <tr> <td> <p> <b>Integra LifeSciences (US)</b> </p> </td> <td> <p> SeaSpine (US) </p> </td> <td> <p> Orthopaedic (spinal) </p> </td> <td> <p> $89m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/orthopaedics/Integra-fuses-with-SeaSpine-for-89m-316137?autnID=/contentstore/clinica/codex/30b18fbd-86cf-11e0-9076-f763394e0062.xml">May 2011</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Nestlé (Switzerland)</b> </p> </td> <td> <p> Prometheus Laboratories (US) </p> </td> <td> <p> In vitro diagnostics </p> </td> <td> <p> $1bn (rumoured) </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/ivds/Nestle-breaks-into-diagnostics-acquiring-Prometheus-for-rumoured-1bn-316141?autnID=/contentstore/clinica/codex/c5080f14-86bf-11e0-9076-f763394e0062.xml">May 2011</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>EKF Diagnostics (UK)</b> </p> </td> <td> <p> Stanbio Laboratory (US) </p> </td> <td> <p> In vitro diagnostics </p> </td> <td> <p> $25.5m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/ivds/EKF-boosts-US-presence-with-Stanbio-acquisition-and-Alere-distribution-deal-316085?autnID=/contentstore/clinica/codex/66a998ac-85f4-11e0-9076-f763394e0062.xml">May 2011</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Lab21 (UK)</b> </p> </td> <td> <p> Myconostica (UK) </p> </td> <td> <p> In vitro diagnostics (fungal infection testing) </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/ivds/Lab21-strengthens-fungal-infection-testing-presence-with-Myconostica-buy-316021?autnID=/contentstore/clinica/codex/66ea7512-853f-11e0-9076-f763394e0062.xml">May 2011</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Thermo Fisher Scientific (US)</b> </p> </td> <td> <p> Phadia (Sweden) </p> </td> <td> <p> In vitro diagnostics (allergy testing) </p> </td> <td> <p> &euro;2.47bn </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/ivds/Thermo-Fisher-bags-global-allergy-testing-leader-Phadia-for-3.5bn-315894">May 2011</a> </p> </td> <td> <p> August 2011 </p> </td> </tr> <tr> <td> <p> <b>Shire (Ireland)</b> </p> </td> <td> <p> Advanced BioHealing (US) </p> </td> <td> <p> Regenerative medicine </p> </td> <td> <p> $750m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/surgicalwoundcare/Advanced-BioHealing-snapped-up-by-UKs-Shire-ahead-of-IPO-315879">May 2011</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Stryker (US)</b> </p> </td> <td> <p> Orthovita (US) </p> </td> <td> <p> Orthopaedics (orthobiologics and biosurgery) </p> </td> <td> <p> $316m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/other/Orthovita-board-comes-under-fire-for-clearing-Strykers-316m-deal-315846">May 2011</a> </p> </td> <td> <p> June 2011 </p> </td> </tr> <tr> <td> <p> <b>Grifols (Spain)</b> </p> </td> <td> <p> Talecris Biotherapeutics (US) </p> </td> <td> <p> Blood plasma products </p> </td> <td> <p> $4bn </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/other/Grifols-asset-sell-off-paves-way-for-4bn-US-blood-products-deal-315137">May 2011</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>GE Healthcare (UK)</b> </p> </td> <td> <p> Applied Precision (US) </p> </td> <td> <p> Imaging </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/imagingit/GE-expands-research-offering-with-Applied-Precision-buy-314980">May 2011</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>APRIL</b> </p> </td> <td><p></td> <td><p></td> <td><p></td> <td><p></td> <td><p></td> </tr> <tr> <td> <p> <b>Myriad Genetics (US)</b> </p> </td> <td> <p> Rules-Based Medicine (RBM, US) </p> </td> <td> <p> In vitro diagnostics </p> </td> <td> <p> $80m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/ivds/Myriad-diversifies-companion-Dx-portfolio-with-RBM-purchase-314847?autnID=/contentstore/clinica/codex/c7715e5b-719b-11e0-a283-2f0f5a919222.xml">April 2011</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Toshiba Medical Systems (Japan)</b> </p> </td> <td> <p> Vital Images (US) </p> </td> <td> <p> Diagnostic imaging/informatics </p> </td> <td> <p> $273m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/imagingit/Vital-Images-buy-helps-Toshiba-sharpen-focus-on-advanced-visualisation-314842?autnID=/contentstore/clinica/codex/07678142-7179-11e0-a283-2f0f5a919222.xml">April 2011</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>GE Healthcare (UK)</b> </p> </td> <td> <p> Steady State Imaging (US) </p> </td> <td> <p> Diagnostic imaging </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/imagingit/GE-gains-new-MRI-imaging-tech-with-Steady-State-acquisition-314451?autnID=/contentstore/clinica/codex/aac85e7c-6a9e-11e0-a283-2f0f5a919222.xml">April 2011</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Baxter International (US)</b> </p> </td> <td> <p> Prism Pharmaceuticals (US) </p> </td> <td> <p> Pharmaceuticals/drug delivery </p> </td> <td> <p> $338m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/other/Baxter-expands-medication-delivery-business-with-338m-Prism-buy-314306?autnID=/contentstore/clinica/codex/0e8c5b50-69c8-11e0-a283-2f0f5a919222.xml">April 2011</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Ion Beam Applications (IBA, Belgium)</b> </p> </td> <td> <p> PET Net (25% stake, Germany) </p> </td> <td> <p> Radiopharmaceuticals </p> </td> <td> <p> &euro;2.5-3m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/business/deals/IBA-expands-into-Germany-with-PET-Net-minority-stake-acquisition-314407?autnID=/contentstore/clinica/codex/f5771efa-6a74-11e0-a283-2f0f5a919222.xml">April 2011</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Johnson &amp; Johnson (US)</b> </p> </td> <td> <p> Synthes (US) </p> </td> <td> <p> Orthopaedics </p> </td> <td> <p> $20bn (unconfirmed) </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/orthopaedics/JandJ-agrees-21bn-price-tag-for-Synthes-314717?autnID=/contentstore/clinica/codex/b0e63e76-70b7-11e0-a283-2f0f5a919222.xml">April 2011</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Alliance HealthCare (US)</b> </p> </td> <td> <p> 24/7 Radiology (US) </p> </td> <td> <p> Imaging </p> </td> <td> <p> $5m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/imagingit/Alliance-HealthCare-continues-on-acquisition-trail-with-247-Radiology-buy-314194?autnID=/contentstore/clinica/codex/1425c1e5-6753-11e0-bead-71c428c80995.xml">April 2011</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Alliance Oncology (US)</b> </p> </td> <td> <p> US Radiosurgery (US) </p> </td> <td> <p> Radiotherapy </p> </td> <td> <p> $54m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/other/Alliance-Oncology-grabs-No1-spot-in-stereotactic-radiosurgery-with-acquisition-314103?autnID=/contentstore/clinica/codex/d585cde8-668e-11e0-bead-71c428c80995.xml">April 2011</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Nordic Capital Fund VII (Nordic region)</b> </p> </td> <td> <p> The Binding Site (UK) </p> </td> <td> <p> In vitro diagnostics </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/ivds/The-Binding-site-joins-Nordic-Capitals-portfolio-314076?autnID=/contentstore/clinica/codex/541c657b-65e8-11e0-bead-71c428c80995.xml">April 2011</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Endo Pharmaceuticals (US)</b> </p> </td> <td> <p> American Medical Systems (US) </p> </td> <td> <p> Urology/pelvic health </p> </td> <td> <p> $2.9bn </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/other/Endo-to-expand-presence-in-devices-market-with-American-Medical-Systems-buy-313896">April 2011</a> </p> </td> <td> <p> June 2011 </p> </td> </tr> <tr> <td> <p> <b>Synergy Health (UK)</b> </p> </td> <td> <p> BeamOne (US) </p> </td> <td> <p> Sterilisation services </p> </td> <td> <p> $35m plus milestone payments of up to $20m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/business/manda/Synergy-Health-enters-US-market-with-BeamOne-buy-313819?autnID=/contentstore/clinica/codex/1afada61-61e4-11e0-946d-8b8f0eccfab8.xml">April 2011</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>LabCorp (US)</b> </p> </td> <td> <p> Orchid Cellmark (US) </p> </td> <td> <p> Molecular diagnostics </p> </td> <td> <p> $85.4m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/ivds/LabCorp-boosts-DNA-test-offering-with-Orchid-buy-313711?autnID=/contentstore/clinica/codex/7329b9d0-6105-11e0-946d-8b8f0eccfab8.xml">April 2011</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Esaote (Italy) / Pie Medical Imaging (the Netherlands)</b> </p> </td> <td> <p> 3mensio Medical Imaging (the Netherlands) </p> </td> <td> <p> Healthcare IT/imaging </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/imagingit/Esaote-to-boost-imaging-IT-offering-with-3mensio-buy-313674?autnID=/contentstore/clinica/codex/1ea2b449-6059-11e0-946d-8b8f0eccfab8.xml">April 2011</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>3M (US)</b> </p> </td> <td> <p> Zargis Medical's Cardioscan software (US) </p> </td> <td> <p> Cardiology diagnostics </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/cardiovascular/3M-acquires-Zargiss-heart-diagnostic-tech-313530?autnID=/contentstore/clinica/codex/3ea0c79b-5ec4-11e0-946d-8b8f0eccfab8.xml">April 2011</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>CSC (US)</b> </p> </td> <td> <p> iSoft (Australia) </p> </td> <td> <p> Healthcare IT </p> </td> <td> <p> $0.17 per share </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/imagingit/CSC-makes-iSoft-takeover-bid-official-313527?autnID=/contentstore/clinica/codex/2323c744-5eba-11e0-946d-8b8f0eccfab8.xml">April 2011</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Qiagen (the Netherlands)</b> </p> </td> <td> <p> Cellestis (Australia) </p> </td> <td> <p> Molecular diagnostics </p> </td> <td> <p> Aus$341m (upped bid to Aus$365m in <a href="http://www.clinica.co.uk/marketsector/ivds/Qiagen-sweetens-Cellestis-bid-by-7-to-speed-up-completion-318347">July</a>) </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/ivds/Qiagen-to-acquire-pre-molecular-diags-firm-Cellestis-for-354m-313519?autnID=/contentstore/clinica/codex/68ec37db-5ea9-11e0-946d-8b8f0eccfab8.xml">April 2011</a> </p> </td> <td> <p> August 2011 </p> </td> </tr> <tr> <td> <p> <b>MARCH</b> </p> </td> <td><p></td> <td><p></td> <td><p></td> <td><p></td> <td><p></td> </tr> <tr> <td> <p> <b>Hitachi Medical (Japan) </b> </p> <p></td> <td> <p> Aloka (Japan) </p> <p></td> <td> <p> Imaging </p> <p></td> <td> <p> Yen25.6bn for 87.56% stake; owned 12.35% since 2006 </p> <p></td> <td> <p> March 2011 </p> <p></td> <td><p></td> </tr> <tr> <td> <p> <b>CryoLife (US)</b> </p> </td> <td> <p> Cardiogenesis (US) </p> </td> <td> <p> Cardiology </p> </td> <td> <p> $22m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/cardiovascular/CryoLife-expands-cardiovascular-offering-with-22m-Cardiogenesis-buy-313286?autnID=/contentstore/clinica/codex/f3abd5ba-5ada-11e0-90cf-cdb443b38086.xml">March 2011</a> </p> </td> <td> <p> May 2011 </p> </td> </tr> <tr> <td> <p> <b>Align Technologies (US)</b> </p> </td> <td> <p> Cadent (US) </p> </td> <td> <p> Dental/orthodontic </p> </td> <td> <p> $190m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/orthopaedics/Align-acquires-dental-scanning-firm-Cadent-for-190m-313271?autnID=/contentstore/clinica/codex/01ad1b1f-5abf-11e0-90cf-cdb443b38086.xml">March 2011</a> </p> </td> <td> <p> April 2011 </p> </td> </tr> <tr> <td> <p> <b>PerkinElmer (US)</b> </p> </td> <td> <p> CambridgeSoft (US) </p> </td> <td> <p> Software/computing </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/imagingit/PerkinElmer-to-buy-software-firm-CambridgeSoft-closes-ArtusLabs-buy-313119?autnID=/contentstore/clinica/codex/e727c5fe-56ce-11e0-961c-a3d9542751c8.xml">March 2011 </a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>China Kanghui (China)</b> </p> </td> <td> <p> Majority stake in Beijing Wei Rui Li Medical Device (China) </p> </td> <td> <p> Orthopaedic </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/orthopaedics/China-Kanghui-buys-into-recon-implant-market-Q4-revenue-growth-healthy-313087?autnID=/contentstore/clinica/codex/0c0552c5-562c-11e0-961c-a3d9542751c8.xml">March 2011</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>HIG Capital (US) </b> </p> </td> <td> <p> Teleflex's marine business (US) </p> </td> <td> <p> Marine - Teleflex is selling off to become pure-play medical device company </p> </td> <td> <p> $121.6m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/business/manda/Teleflex-offloads-marine-business-to-concentrate-on-med-tech-313001?autnID=/contentstore/clinica/codex/443d5427-5541-11e0-961c-a3d9542751c8.xml">March 2011</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Becton Dickinson (US)</b> </p> </td> <td> <p> Accuri Cytometers (US) </p> </td> <td> <p> Flow cytometry/IVDs </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/ivds/BD-acquires-Accuri-Cytometers-312917?autnID=/contentstore/clinica/codex/f60e1044-53ce-11e0-961c-a3d9542751c8.xml">March 2011</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Utah Medical Products (US)</b> </p> </td> <td> <p> Femcare (UK) </p> </td> <td> <p> Women's health/contraception </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/other/Femcare-buy-to-grow-Utahs-gynaecology-portfolio-and-non-US-sales-312896?autnID=/contentstore/clinica/codex/c2dceff6-53b5-11e0-961c-a3d9542751c8.xml">March 2011</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Quest Diagnostics (US) </b> </p> </td> <td> <p> Celera (US) </p> </td> <td> <p> Molecular diagnostics </p> </td> <td> <p> $344 (excluding $327m of Celera's cash and short-term investments) </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/ivds/Quest-strengthens-personalised-medicine-pipeline-with-671m-Celera-buy-312864?autnID=/contentstore/clinica/codex/43cb7c3b-5174-11e0-961c-a3d9542751c8.xml">March 2011</a> </p> </td> <td> <p> May 2011 </p> </td> </tr> <tr> <td> <p> <b>Biomedical Structures (US)</b> </p> </td> <td> <p> Concordia Medical (US) </p> </td> <td> <p> Biomedical textiles for medical devices </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/cellulargenetic/Biomedical-Structures-buys-biomaterial-firm-Concordia-Medical-312704?autnID=/contentstore/clinica/codex/40053e37-4fc2-11e0-961c-a3d9542751c8.xml">March 2011</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Roche (Switzerland)</b> </p> </td> <td> <p> PVT Probenverteiltechnik (Germany) </p> </td> <td> <p> IVDs </p> </td> <td> <p> &euro;85m (upfront fee of &euro;65m plus milestones of up to &euro;20m) </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/ivds/Roche-strengthens-lab-automation-competence-with-PVT-buy-312665?autnID=/contentstore/clinica/codex/9dffabee-4ef4-11e0-961c-a3d9542751c8.xml">March 2011</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Edwards Lifesciences (US) </b> </p> </td> <td> <p> Embrella Cardiovascular (US) </p> </td> <td> <p> Cardiovascular/stroke </p> </td> <td> <p> $43m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/cardiovascular/Edwards-buys-Embrella-for-43m-312599?autnID=/contentstore/clinica/codex/4fc27edb-4e33-11e0-8b00-cbbda958c709.xml">March 2011 </a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Halma (UK)</b> </p> </td> <td> <p> Medicel (Switzerland) </p> </td> <td> <p> Ophthalmology </p> </td> <td> <p> CHF70m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/other/Halma-bulks-up-optical-offering-with-Medicel-buy-312457?autnID=/contentstore/clinica/codex/5698b9ff-4b19-11e0-8b00-cbbda958c709.xml">March 2011</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Fresenius Medical Care (Germany) </b> </p> </td> <td> <p> Hema Metrics&rsquo; Crit-Line system (US) </p> </td> <td> <p> Haemodialysis monitoring </p> </td> <td> <p> Up to $25m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/other/Fresenius-acquires-Hema-Metrics-Crit-Line-monitoring-products-312455?autnID=/contentstore/clinica/codex/1e194692-4b29-11e0-8b00-cbbda958c709.xml">March 2011</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Philips (Netherlands)</b> </p> </td> <td> <p> Dameca (Denmark) </p> </td> <td> <p> Anaesthesia devices </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/other/Philips-strengthens-anaesthesia-offering-with-Dameca-buy-312465?autnID=/contentstore/clinica/codex/1f8ad72f-4a70-11e0-8b00-cbbda958c709.xml">March 2011</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Accuray (US) </b> </p> </td> <td> <p> TomoTherapy (US) </p> </td> <td> <p> Radiotherapy </p> </td> <td> <p> $277m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/other/Accuray-moves-to-acquire-TomoTherapy-but-shareholders-want-better-price-312339?autnID=/contentstore/clinica/codex/092b8b33-4998-11e0-8b00-cbbda958c709.xml">March 2011</a> </p> </td> <td> <p> June 2011 </p> </td> </tr> <tr> <td> <p> <b>Terumo (Japanese)</b> </p> </td> <td> <p> CaridianBCT (US) </p> </td> <td> <p> Blood transfusion products </p> </td> <td> <p> $2.6bn </p> </td> <td> <p> <a href="http://www.clinica.co.uk/business/manda/Terumo-soars-to-No-1-in-global-blood-transfusion-with-2.6bn-CaridianBCT-buy-312275?autnID=/contentstore/clinica/codex/56d06321-497a-11e0-8b00-cbbda958c709.xml">March 2011</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Physio-Control (US)</b> </p> </td> <td> <p> Jolife (Sweden) </p> </td> <td> <p> Cardiovascular (emergency products) </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/cardiovascular/Physio-Control-acquires-Jolife-312036">March 2011</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>FEBRUARY</b> </p> </td> <td><p></td> <td><p></td> <td><p></td> <td><p></td> <td><p></td> </tr> <tr> <td> <p> <b>TiGenix (Belgium)</b> </p> </td> <td> <p> Cellerix (Spain) </p> </td> <td> <p> Stem cell therapies </p> </td> <td> <p> &euro;58 </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/cellulargenetic/TiGenix-bulks-up-in-merger-with-Cellerix-311835?autnID=/contentstore/clinica/codex/aa651aca-40f6-11e0-8b00-cbbda958c709.xml">February 2011</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Eurofins Scientific (Belgium)</b> </p> </td> <td> <p> Thermo Fisher's Lancaster Labs division (US) </p> </td> <td> <p> Lab services </p> </td> <td> <p> $200m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/imagingit/Thermo-Fisher-offloads-Athena-and-Lancaster-units-for-940m-311789?autnID=/contentstore/clinica/codex/f2c0bb3c-403b-11e0-8b00-cbbda958c709.xml">February 2011</a> </p> </td> <td> <p> April 2011 </p> </td> </tr> <tr> <td> <p> <b>Quest Diagnostics (US)</b> </p> </td> <td> <p> Thermo Fisher's Athena Diagnostics division (US) </p> </td> <td> <p> Molecular diagnostics for neurological disorders </p> </td> <td> <p> $740m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/imagingit/Thermo-Fisher-offloads-Athena-and-Lancaster-units-for-940m-311789?autnID=/contentstore/clinica/codex/f2c0bb3c-403b-11e0-8b00-cbbda958c709.xml">February 2011</a> </p> </td> <td> <p> April 2011 </p> </td> </tr> <tr> <td> <p> <b>Best Medical Belgium (Belgium)</b> </p> </td> <td> <p> Nordion's Belgian operations (Belgium) </p> </td> <td> <p> Nuclear imaging (FDG imaging agent and cyclotron and reactor isotopes), and gamma radiography products </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/imagingit/Nordion-to-sell-Belgian-business-to-Best-Medical-311687?autnID=/contentstore/clinica/codex/070b82f1-3f3b-11e0-8b00-cbbda958c709.xml">February 2011</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Boston Scientific (US)</b> </p> </td> <td> <p> ReVascular Therapeutics (US) </p> </td> <td> <p> Cardiovascular (treatment of arterial occlusion) </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/cardiovascular/Boston-Scientific-bulks-up-peripheral-artery-device-offering-311418">February 2011</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Sonoma Orthopedic Products (US)</b> </p> </td> <td> <p> Fracture fixation technology from NovaLign Orthopaedics (US) </p> </td> <td> <p> Orthopaedics </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/orthopaedics/Sonoma-buys-fracture-fixation-technology-from-NovaLign-311314">February 2011</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Global Capital Management (Middle East)</b> </p> </td> <td> <p> 80% of B?&ccedil;akc?lar T?bbi Cihazlar (Turkey) </p> </td> <td> <p> Medical disposable products and capital equipment, and distributor of cardiovascular and neurosurgery products </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/Investment-firm-buys-80-stake-in-leading-Turkish-medtech-manufacturer-311200">February 2011</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Danaher (US)</b> </p> </td> <td> <p> Beckman Coulter (US) </p> </td> <td> <p> In vitro diagnostics and lab systems </p> </td> <td> <p> $6.8bn </p> </td> <td> <p> <a href="http://www.clinica.co.uk/business/manda/Danaher-to-acquire-Beckman-Coulter-in-6.8bn-deal-309791">February 2011</a> </p> </td> <td> <p> June 2011 </p> </td> </tr> <tr> <td> <p> <b>Frazier Healthcare (US)</b> </p> </td> <td> <p> Laboratory Supply Company (LABSCO, US) </p> </td> <td> <p> Diagnostic instrumentation and clinical laboratory products </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/ivds/LABSCO-bought-by-venture-capital-firm-309800?autnID=/contentstore/clinica/codex/44416841-32c8-11e0-8715-3761697eee86.xml">February 2011</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Medline (US)</b> </p> </td> <td> <p> CareFusion's International Surgical Products distribution business (US) </p> </td> <td> <p> Medical consumable products </p> </td> <td> <p> $130m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/business/manda/CareFusion-casts-off-surg-products-distribution-unit-to-Medline-309633?autnID=/contentstore/clinica/codex/9ef288e5-2fac-11e0-8715-3761697eee86.xml">February 2011</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>JANUARY</b> </p> </td> <td><p></td> <td><p></td> <td><p></td> <td><p></td> <td><p></td> </tr> <tr> <td> <p> <b>Arthrex (US)</b> </p> </td> <td> <p> Cardo Medical's joint arthroplasty business (US) </p> </td> <td> <p> Orthopaedics </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/orthopaedics/Arthrex-to-purchase-struggling-Cardos-joint-arthroplasty-division-309194?autnID=/contentstore/clinica/codex/8690c38a-2963-11e0-a765-d94a6db3342c.xml">January 2011</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Novartis (Switzerland)</b> </p> </td> <td> <p> Genoptix (US) </p> </td> <td> <p> In vitro diagnostics </p> </td> <td> <p> $470m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/ivds/Novartis-boosts-companion-diagnostics-focus-with-470m-Genoptix-buy-309071?autnID=/contentstore/clinica/codex/0f6b16c4-27cd-11e0-a34c-8943a1c0c9ca.xml">January 2011</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Boston Scientific (US)</b> </p> </td> <td> <p> Atritech (US) </p> </td> <td> <p> Cardiovascular (left atrial appendage closure technology) </p> </td> <td> <p> 100m plus milestone payments of up to $275m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/cardiovascular/Boston-extends-MandA-activity-with-375m-deal-for-Atritech-308839?autnID=/contentstore/clinica/codex/aa8c88fb-23e3-11e0-a34c-8943a1c0c9ca.xml">January 2011</a> </p> </td> <td> <p> March 2011 </p> </td> </tr> <tr> <td> <p> <b>Rochester Medical (US)</b> </p> </td> <td> <p> Laprolan (the Netherlands) </p> </td> <td> <p> Importer and distributor of medical products including wound care, ostomy care and urology products </p> </td> <td> <p> $13.7m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/surgicalwoundcare/Rochester-to-go-direct-in-the-Netherlands-with-Laprolan-buy-308708?autnID=/contentstore/clinica/codex/3fccaed1-2233-11e0-92f3-cf1dfcf723f1.xml">January 2011</a> </p> </td> <td> <p> April 2011 </p> </td> </tr> <tr> <td> <p> <b>Globus Medical (US)</b> </p> </td> <td> <p> Facet Solutions (US) </p> </td> <td> <p> Orthopaedics (total facet arthroplasty devices) </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/orthopaedics/Globus-adds-Facet-Solutions-to-ortho-portfolio-308568?autnID=/contentstore/clinica/codex/59a7b119-1f0e-11e0-92f3-cf1dfcf723f1.xml">January 2011</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Vycor Medical (US)</b> </p> </td> <td> <p> NovaVision (US) </p> </td> <td> <p> Optical devices (vision restoration technology) </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/other/Vycor-gains-vision-restoration-tech-through-NovaVision-buy-308538?autnID=/contentstore/clinica/codex/1cfd6573-1e45-11e0-92f3-cf1dfcf723f1.xml">January 2011</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Teleflex (US)</b> </p> </td> <td> <p> VasoNova (US) </p> </td> <td> <p> Cardiovascular (central venous catheter navigation technology) </p> </td> <td> <p> $25m plus milestone payments of $15-30m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/cardiovascular/Teleflex-buys-VasoNova-to-enhance-medtech-focus-308430?autnID=/contentstore/clinica/codex/2eb4c4ac-1d76-11e0-92f3-cf1dfcf723f1.xml">January 2011</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Hologic (US)</b> </p> </td> <td> <p> Interlace Medical (US) </p> </td> <td> <p> Women's health </p> </td> <td> <p> $125m plus two annual contingent payments </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/other/Hologic-fleshes-out-urogynae-offering-with-Interlace-Medical-buy-308316?autnID=/contentstore/clinica/codex/cc108662-1cb8-11e0-94c9-9db12beab216.xml">January 2011</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Surface Technology International (STI, UK)</b> </p> </td> <td> <p> Cardionetics (UK) </p> </td> <td> <p> Handheld ECG monitors </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/cardiovascular/STI-Capital-buys-Cardionetics-for-ECG-boost-308227?autnID=/contentstore/clinica/codex/3410def7-1a63-11e0-94c9-9db12beab216.xml">January 2011</a> </p> </td> <td><p></td> </tr> <tr><td> <p> <b>Boston Scientific (US)</b> </p> </td> <td> <p> Intelect Medical (US) </p> </td> <td> <p> Neurology (deep brain stimulation) </p> </td> <td> <p> $78m </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/neurological/Boston-gains-deep-brain-stimulation-tech-with-Intelect-buy-308160?autnID=/contentstore/clinica/codex/287d431c-19a9-11e0-973d-774b2a893566.xml">January 2011</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Philips Healthcare (the Netherlands)</b> </p> </td> <td> <p> medSage Technologies' home patient monitoring business (US) </p> </td> <td> <p> Patient monitoring </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/other/Philips-inhales-medSages-home-monitoring-apps-business-308165?autnID=/contentstore/clinica/codex/d887c44b-19a1-11e0-973d-774b2a893566.xml">January 2011</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>Lab21 (UK)</b> </p> </td> <td> <p> Microgen Bioproducts (UK) </p> </td> <td> <p> In vitro diagnostics </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a href="http://www.clinica.co.uk/marketsector/ivds/Lab21-grows-infectious-disease-test-portfolio-with-Microgen-buy-308162?autnID=/contentstore/clinica/codex/a6e756dd-19a2-11e0-973d-774b2a893566.xml">January 2011</a> </p> </td> <td><p></td> </tr> <tr> <td> <p> <b>DECEMBER</b> </p> </td> <td><p></td> <td><p></td> <td><p></td> <td><p></td> <td><p></td> </tr> <tr> <td> <p> <b>MiMedx (US)</b> </p> </td> <td> <p> Surgical Biologics (US) </p> </td> <td> <p> Surgical implants </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a target="_blank" href="http://www.clinica.co.uk/marketsector/orthopaedics/MiMedx-to-buy-Surgical-Biologics-for-biomaterial-boost-308021?autnID=/contentstore/clinica/codex/1050e291-1819-11e0-973d-774b2a893566.xml">December 2010</a> </p> </td> <td> <p> January 2011 </p> </td> </tr> <tr> <td> <p> <b>SyntheMed (US)</b> </p> </td> <td> <p> Pathfinder (US) </p> </td> <td> <p> Regenerative medicine </p> </td> <td> <p> Undisclosed merger </p> </td> <td> <p> <a target="_blank" href="http://www.clinica.co.uk/marketsector/cellulargenetic/SyntheMed-and-Pathfinder-merge-to-create-cell-based-tech-firm-307979?autnID=/contentstore/clinica/codex/54f81673-14d1-11e0-9640-ef40dd2c48dc.xml">December 2010</a> </p> </td> <td> <p> <i>Pending</i> </p> </td> </tr> <tr> <td> <p> <b>Zimmer (US)</b> </p> </td> <td> <p> Sodem Diffusion (Switzerland) </p> </td> <td> <p> Surgical power tools </p> </td> <td> <p> Undisclosed </p> </td> <td><p></td> <td> <p> <a target="_blank" href="http://www.clinica.co.uk/marketsector/orthopaedics/Zimmer-buys-Sodem-Diffusion-for-power-tools-boost-307849?autnID=/contentstore/clinica/codex/0cef6da3-0e8d-11e0-9640-ef40dd2c48dc.xml">December 2010</a> </p> </td> </tr> <tr> <td> <p> <b>Pritzker Group (US)</b> </p> </td> <td> <p> Clinical Innovations (US) </p> </td> <td> <p> Women's health </p> </td> <td> <p> Undisclosed </p> </td> <td><p></td> <td> <p> December 2010 </p> </td> </tr> <tr> <td> <p> <b>Gen-Probe (US)</b> </p> </td> <td> <p> GTI Diagnostics (US) </p> </td> <td> <p> Transplant diagnostics </p> </td> <td> <p> $53m </p> </td> <td><p></td> <td> <p> <a target="_blank" href="http://www.clinica.co.uk/marketsector/ivds/Gen-Probe-acquires-blood-diagnostics-specialist-GTI-307693?autnID=/contentstore/clinica/codex/2c93ffe4-0d01-11e0-9640-ef40dd2c48dc.xml">December 2010</a> </p> </td> </tr> <tr> <td> <p> <b>Chart Industries (US)</b> </p> </td> <td> <p> SeQual Technologies (US) </p> </td> <td> <p> Air separation technology </p> </td> <td> <p> $40m </p> </td> <td> <p> December 2010 </p> </td> <td> <p> <i>Pending</i> </p> </td> </tr> <tr> <td> <p> <b>Samsung (Korea)</b> </p> </td> <td> <p> Medison (Korea) </p> </td> <td> <p> Medical equipment </p> </td> <td> <p> Undisclosed </p> </td> <td><p></td> <td> <p> December 2010 </p> </td> </tr> <tr> <td> <p> <b>iCAD (US)</b> </p> </td> <td> <p> Xoft (US) </p> </td> <td> <p> Brachytherapy </p> </td> <td> <p> $13.1m </p> </td> <td> <p> <a target="_blank" href="http://www.clinica.co.uk/marketsector/other/iCAD-enters-cancer-treatment-sector-with-Xoft-buy-307647?autnID=/contentstore/clinica/codex/58bd8f7e-0c36-11e0-9640-ef40dd2c48dc.xml">December 2010</a> </p> </td> <td> <p> December 2010 </p> </td> </tr> <tr> <td> <p> <b>Thermo Fisher (US)</b> </p> </td> <td> <p> Dionex (US) </p> </td> <td> <p> Chromatography </p> </td> <td> <p> $2.1bn </p> </td> <td> <p> December 2010 </p> </td> <td> <p> <i>Pending</i> </p> </td> </tr> <tr> <td> <p> <b>Galderma (US)</b> </p> </td> <td> <p> Q-Med (Sweden) </p> </td> <td> <p> Medical implants </p> </td> <td> <p> SEK75 ($11) per share </p> </td> <td> <p> <a target="_blank" href="http://www.clinica.co.uk/marketsector/Nestle-and-LOreal-joint-venture-to-make-bid-for-Q-Med-307456?autnID=/contentstore/clinica/codex/a920ed01-085e-11e0-9640-ef40dd2c48dc.xml">December 2010</a> </p> </td> <td> <p> <i>Pending</i> </p> </td> </tr> <tr> <td> <p> <b>3i (UK)</b> </p> </td> <td> <p> OneMed Group from CapMan (Norway) </p> </td> <td> <p> Medical device wholesaler </p> </td> <td> <p> Undisclosed </p> </td> <td><p></td> <td> <p> <a target="_blank" href="http://www.clinica.co.uk/marketsector/OneMed-sold-to-3i-in-private-equity-deal-307363?autnID=/contentstore/clinica/codex/5b053692-076e-11e0-bd26-b56fabe1b06f.xml">December 2010</a> </p> </td> </tr> <tr> <td> <p> <b>Phadia (Sweden)</b> </p> </td> <td> <p> Wei Kang Le (China) </p> </td> <td> <p> Device distributor </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a target="_blank" href="http://www.clinica.co.uk/marketsector/ivds/Phadia-set-to-buy-Chinese-allergy-test-distributor-307303?autnID=/contentstore/clinica/codex/99bc02c5-06ce-11e0-bd26-b56fabe1b06f.xml">December 2010</a> </p> </td> <td> <p> <i>Pending</i> </p> </td> </tr> <tr> <td> <p> <b>Synergy Health (UK)</b> </p> </td> <td> <p> Gamma-Service-Produktbestrahlung (Germany) </p> </td> <td> <p> Device sterilisation </p> </td> <td> <p> &euro;9.5m ($12.6m) </p> </td> <td><p></td> <td> <p> <a target="_blank" href="http://www.clinica.co.uk/marketsector/Synergy-Health-grows-European-sterilisation-business-307312?autnID=/contentstore/clinica/codex/53c946f6-06b2-11e0-bd26-b56fabe1b06f.xml">December 2010</a> </p> </td> </tr> <tr> <td> <p> <b>Olympus (Japan)</b> </p> </td> <td> <p> Stryker's OP-1 family of biological bone substitutes (US) </p> </td> <td> <p> Orthopaedic </p> </td> <td> <p> $60m </p> </td> <td> <p> <a target="_blank" href="http://www.clinica.co.uk/marketsector/orthopaedics/Stryker-offloads-troubled-orthobiologics-line-to-Olympus-for-60m-307020?autnID=/contentstore/clinica/codex/bb9bfbef-0217-11e0-a987-953107add0d4.xml">December 2010</a> </p> </td> <td> <p> <i>Pending</i> </p> </td> </tr> <tr> <td> <p> <b>Axis-Shield (UK)</b> </p> </td> <td> <p> Clinical chemistry homocysteine business from Catch (US) </p> </td> <td> <p> IVD </p> </td> <td> <p> $10m and 10% products revenue for the life of the technology </p> </td> <td> <p> <a target="_blank" href="http://www.clinica.co.uk/marketsector/ivds/Axis-Shield-to-acquire-homocysteine-testing-products-from-Catch-307019?autnID=/contentstore/clinica/codex/fc2823f7-0216-11e0-a987-953107add0d4.xml">December 2010</a> </p> </td> <td> <p> <i>Pending</i> </p> </td> </tr> <tr> <td> <p> <b>Transgenomic (US)</b> </p> </td> <td> <p> Genetic and companion diagnostic testing business of Clinical Data (US) </p> </td> <td> <p> IVD </p> </td> <td> <p> $15.4m cash and stock, plus milestones </p> </td> <td> <p> <a target="_blank" href="http://www.clinica.co.uk/marketsector/ivds/Transgenomic-to-acquire-molecular-Dx-tech-from-Clinical-Data-306940?autnID=/contentstore/clinica/codex/f1e71bb6-0149-11e0-a987-953107add0d4.xml">December 2010</a> </p> </td> <td> <p> December 2010 </p> </td> </tr> <tr> <td> <p> <b>Thermo Fisher Scientific (US)</b> </p> </td> <td> <p> Lomb Scientific (Australia) </p> </td> <td> <p> Laboratory consumables and instruments </p> </td> <td> <p> Undisclosed </p> </td> <td> <p> <a target="_blank" href="http://www.clinica.co.uk/business/manda/Thermos-Lomb-buy-to-expand-Asia-Pacific-presence-306882?autnID=/contentstore/clinica/codex/da954ab6-feef-11df-a987-953107add0d4.xml">December 2010</a> </p> </td> <td> <p> December 2010 </p> </td> </tr> <tr> <td> <p> <b>EKF Diagnostics (Germany)</b> </p> </td> <td> <p> Argutus Medical (Ireland) </p> </td> <td> <p> IVD </p> </td> <td> <p> &pound;2.2m ($3.3m) </p> </td> <td><p></td> <td> <p> <a target="_blank" href="http://www.clinica.co.uk/marketsector/ivds/Refocused-EKF-snaps-up-Argutus-as-third-IVD-buy-306873?autnID=/contentstore/clinica/codex/a21e9fbc-fed1-11df-a987-953107add0d4.xml">December 2010</a> </p> </td> </tr> </table> <p> <a class="optionsLink" href="http://www.clinica.co.uk/MnA#top">Back to the top</a><br> <br> <a name="latest" id="latest"> </a> </p> 
----field----
field: {0212FC0F-953B-461C-B4D9-B7483A4D4F1B}
name: Taxonomy
key: taxonomy
content-length: 38

{2EDCC1FF-26E4-4C6E-AF73-0F43F0F033B8}
----field----
field: {8F4EE718-6FA0-42A5-85C4-6C8FE8B1FCD4}
name: Navigation Title
key: navigation title
content-length: 29

Mergers amp Acquisitions 2011
----field----
field: {7C4FC796-1311-4DAA-81AC-85EAA2C1C108}
name: Actual Publish Date
key: actual publish date
content-length: 15

20160622T191404
----field----
field: {1616FE67-7278-4169-948E-C29B00EC8781}
name: Article Number
key: article number
content-length: 8

MT059712
----field----
field: {31603F25-6D9C-4954-BCDE-342E1E184A30}
name: Meta Title Override
key: meta title override
content-length: 31

Mergers &amp; Acquisitions 2011
----field----
field: {0F6C8F42-01DC-4E05-B63E-AA25D8AA0E09}
name: Legacy Publication
key: legacy publication
content-length: 38

{FF38DC83-07D4-43F0-8C55-84EB64FAF35A}
----field----
field: {5795FF15-0942-41FF-8A77-3B73185F5E1B}
name: Escenic ID
key: escenic id
content-length: 6

325786
----field----
field: {25BED78C-4957-4165-998A-CA1B52F67497}
name: __Created
key: __created
content-length: 16

20160622T190958Z
----field----
field: {5DD74568-4D4B-44C1-B513-0AF5F4CDA34F}
name: __Created by
key: __created by
content-length: 18

sitecore\Anonymous
----field----
field: {8CDC337E-A112-42FB-BBB4-4143751E123F}
name: __Revision
key: __revision
content-length: 36

b8be8bb9-cd67-44b6-90c2-aa4ae26596e2
----field----
field: {D9CF14B1-FA16-4BA6-9288-E8A174D4D522}
name: __Updated
key: __updated
content-length: 16

20160622T231404Z
----field----
field: {BADD9CF9-53E0-4D0C-BCC0-2D784C282F6A}
name: __Updated by
key: __updated by
content-length: 14

sitecore\admin
----field----
field: {3E431DE1-525E-47A3-B6B0-1CCBEC3A8C98}
name: __Workflow state
key: __workflow state
content-length: 38

{962542F5-554E-4DE8-BE4C-B0796FDAC854}
